Company description

For more than 40 years, Laboratorios Rubio, a family-owned company, has been recognized for the development, manufacture and marketing of medicines with high therapeutical value for specialists as well as of certain drugs for life-threatening diseases, with long expertise in niche markets. Laboratorios Rubio's determination to meet the health needs of every single patient has lead the company to be distinguished as per being pioneer of products targeted to low incidence diseases which affect only to a small number of patients and that require the development of specific pharmaceutical products to treat them.

Within the niche market strategy Laboratorios Rubió has been pioneer and innovative company among the Spanish laboratories focus on, but not limited to therapeutical areas such as: CNS, Anti-rheumatic, Nephrology, Urology, CV, GI, etc. It is worth highlighting the success of RUBIFEN® RESINCALCIO® and RESINCOLESTIRAMINA®

For more information, please visit us on www.laboratoriosrubio.com


Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Primary business activity Exporter; Importer; Manufacturer
Affiliated categories: Finished Dosage Forms More

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 1A36 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 90A50 See our Exhibitor Profile   See full Exhibitor List

Categories affiliated with LABORATORIOS RUBIO SA


Contact information




View all contact information